Ukwelashwa Okusha Kokufakelwa Kwezinso Kwezinso

A BAMBA MahhalaRelease 6 | eTurboNews | eTN
Ibhalwe ngu Linda Hohnholz

I-Hansa Biopharma AB namuhla imemezele ukuthi isiguli sokuqala esivivinyweni esibalulekile esilawulwayo sase-US esivulekile, esingahleliwe, esilawulwayo (“ConfIdeS”) sibhaliswe e-Columbia University Medical Center, eNew York. Uhlolo lwe-ConfIdeS luhlola i-imlifidase njengendlela yokwelapha engase ibe khona yokususa ukuzwela ukuze kunikwe amandla ukufakelwa kwezinso ezigulini ezizwela kakhulu ezilinde umnikeli oshonile wezinso ngohlelo lwase-US lokunikezwa kwezinso.

Ukuhlolwa kulindeleke ukuthi kuhlele ngokungahleliwe iziguli ezifakelwa izinso ezizwela kakhulu ezingama-64 nge-cPRA engu-≥99.9%, emele isethi yeziguli ezizwela kakhulu eziqhubeka nokuncishwa amathuba naphezu kokubekwa phambili ngaphansi kohlelo lwase-US lokwabiwa kwezinso. Lapho isitho somnikeli sitholakala futhi ukungqubuzana okuhle nomamukeli ohlosiwe kubonisa ukuthi isitho asihambisani, isiguli sizohlelwa ngokungahleliwe ekwelashweni kwe-imlifidase desensitization noma ingalo yokulawula ezothola ukunakekelwa okujwayelekile (okungukuthi ukulinda okuhambisanayo kakhudlwana. ukunikezwa kwezinso noma ukuthola ukwelashwa kokuhlolwa kokuqeda ukungezwani komzimba). Isiphetho esiyinhloko socwaningo se-imlifidase sokuhlola inzuzo ekufakeleni kabusha iziguli ezizwela kakhulu umsebenzi wokufakwa kwezinso ezinyangeni eziyi-12, kukalwa nge-eGFR (i-Glomerular Filtration Rate elinganiselwe).

Imigomo yocwaningo lwe-ConfIdeS ihambisana “Ne-Advancing American Kidney Health” (“AAKH”) US Executive Order (https://kidney360.asnjournals.org/content/1/6/557), egxile ezintweni ezintathu ezibanzi. imigomo: (1) ukunciphisa ingozi yokwehluleka kwezinso; (2) ukuthuthukisa ukufinyelela kanye nekhwalithi yezinketho zokwelashwa ezigxile kumuntu; kanye (3) nokwandisa ukufinyelela ekufakweni kwezinso, okubili kokugcina kuhlanganiswe ngokuqondile nokwandisa ukufakelwa kabusha.

U-Robert A. Montgomery, MD, uProfesa Wokuhlinza kanye noMqondisi, i-NYU Langone Transplant Institute eNew York City, uqokwe njengoMphenyi Kazwelonke Wokuxhumanisa wecala le-ConfIdeS. Ukuhlolwa kuzobhalisa iziguli ezikhungweni ezihola phambili eziyi-12 kuye kweziyi-15 e-US

Ukuphothulwa kokubhaliswa ocwaningweni kulindeleke engxenyeni yesibili ka-2022, kanti isikhathi sokufunda sokulandelela esiyizinyanga eziyi-12 kulindeleke ukuthi siqedwe engxenyeni yesibili ka-2023. Imiphumela yalolu hlolo olubalulekile kulindeleke ukuthi isekele ukuthunyelwa kwe-BLA okungaba khona i-FDA ngaphansi kwendlela yokugunyazwa esheshisiwe engxenyeni yokuqala ka-2024.

I-Imlifidase isivele ithole imvume yokuthengisa enemibandela e-Europe yokwelashwa kokungazweli kweziguli ezikhungathekiswe kakhulu zokufakelwa izinso ezinomphumela omuhle ngokumelene nomnikezeli oshonile otholakalayo.

<

Mayelana umbhali

Linda Hohnholz

Umhleli omkhulu we eTurboNews ezinze eTN HQ.

Bhalisa
Yazisa ngakho
isivakashi
0 Amazwana
Okungaphakathi Okuphakelayo
Buka wonke amazwana
0
Ungathanda imibono yakho, ngicela uphawule.x
Yabelana ku...